AniCell Biotech
- Company typePrivate
- Founded2015
- HeadquartersChandler, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
AniCell Biotech firmographics
Firmographics- Name
- AniCell Biotech
- Legal name
- AniCell Biotech, LLC
- Website
- https://anicellbiotech.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
AniCell Biotech industry classification
Industry- Product category
- Veterinary Regenerative Medicine
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Point-of-Care Regenerative Kits & Devices (Processing/Delivery) (HLAMANAK)
- akta.pro secondary industries
- Wound Healing & Dermatologic Regeneration (HLAMANAG), Stem Cell Therapies (Autologous & Allogeneic) (HLAMANAA), Equine Therapeutics (Rx) (HLAMAEAC)
Keywords
Where AniCell Biotech is headquartered
LocationHeadquarters
- HQ city
- Chandler
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
AniCell Biotech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Veterinary Product Sales: AniCell sells its regenerative amnion-derived products directly to veterinarians who administer treatments to animals. Products include StemWrap, AniMatrX, AniMotion, AniOcular and related product lines for equine and canine applications. Veterinarians order through the Vet Access portal or via sales representatives.
- Distribution Partnership Revenue: Products distributed through MWI Animal Health distributor network, generating revenue through wholesale distribution channels to veterinary practices across the United States.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Stem cell therapy for dogs |
| Unit Pricing | Pay-as-you-go | Quantity discounts available |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels9 records
AniCell Biotech product offering
Product offeringCore offering
AniCell Biotech develops and manufactures ready-to-use, all-natural regenerative bioscaffold products derived from equine amniotic material for veterinary use. The portfolio includes two main brands—EquusCell for horses and CanisCell for dogs—with membrane bandages (StemWrap), injectable allografts (AniMatrX, AniMotion), ophthalmic products (AlloOcular, AniOcular), and temperature-independent formulations (AniCell D line). Products support wound management, tendon and ligament injuries, joint inflammation, and ocular conditions without requiring invasive stem cell harvesting.
Product overview
AniCell Biotech offers regenerative veterinary products derived from equine amniotic material collected non-invasively during parturition. The product portfolio consists of two main brands: EquusCell for horses and CanisCell for dogs. Key products include StemWrap/StemWrap Plus (membrane bandages), AniMatrX/AniMotion (injectable allografts), and AlloOcular (ophthalmic products). Products provide all-natural, minimally manipulated regenerative solutions for wound healing, tendon/ligament injuries, joint inflammation, and ocular conditions without requiring invasive stem cell harvesting.
Differentiator
Problem solved
Functional benefit
Brands
- EquusCell: Product line for horses focusing on regenerative treatment for tendons, ligaments, joints, and superficial wounds
- CanisCell
- AlloMatrix
- AlloMotion
- AlloOcular
- StemWrap
- AniMotion
- AniMatrX
Products and services
- EquusCell
- CanisCell
- StemWrap
- StemWrap Plus
- StemWrap D
- AniMatrX
- AniMatrX-D
- AniMotion
- AlloOcular
- AniOcular
- AlloMatrix
- EquusCell D
- CanisCell StemWrap
Quantifiable outcome
- Horses resumed activities in half the time compared to conventional treatments
- +4 more outcomes
Companies that use AniCell Biotech
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles2 records
AniCell Biotech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
AniCell Biotech partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core, major and minor.
- MWI Animal HealthcoreMWI Animal Health is AniCell's primary distribution partner for veterinary products across the United States. The website displays 'Proud to be distributed by MWI' indicating a formal distribution agreement.
- American Association of Equine Practitioners (AAEP)coreAniCell is a corporate sponsor of AAEP and presents at annual conferences. Hosts AAEP Conference Registration for CE courses. Company has presented at AAEP events for multiple years.
- North American Veterinary Community (VMX Conference)majorExhibits at VMX Conference (Booth 2649) annually, showcasing products to veterinary professionals from around the world.
- Western Veterinary Conference (WVC)majorExhibits at WVC Vegas Conference (Booth 3961) annually with presence in February.
- Lake Tahoe Equine ConferencemajorParticipates in the Forty-Seventh Annual Lake Tahoe Equine Conference (January 26-30, 2026) as an exhibitor and educational supporter.
- TEVA FoundationminorCorporate sponsor of Texas Equine Veterinary Association Foundation events and silent auctions supporting veterinarians in need.
- ISELPminorCorporate sponsor of ISELP (International Society of Equine Professionals). Company logo appears alongside 'Proud to be corporate sponsors of ISELP'.
- Dr. Marty GoldsteinminorPartnership with Dr. Marty Goldstein DVM who lectures on integrative veterinary approaches to promote longevity and wellness through regenerative technologies. Company provides support for his educational presentations.
- North Carolina State University - Schnabel LabcoreDr. Lauren Schnabel at NC State University conducts clinical research on AniCell products including StemWrap wound healing studies. Her lab published peer-reviewed research supporting product efficacy.
- Dr. Moises Barcelo (Dr. Moises Barcelo-Fimbres)coreBioprocess engineer and research veterinarian Dr. Moises Barcelo has developed multiple product lines including EquusCell, CanisCell, and temperature-independent products. Key inventor and technical advisor.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
AniCell Biotech competitors and assessment
Company assessmentBroad incumbents
- Vetoquinol: Vetoquinol is a global animal-health pharma with equine and companion animal therapeutics (including regenerative/orthopedic adjacencies); another broad incumbent that competes for shelf space and CE audiences at AAEP/VMX/WVC where AniCell also markets.
- Heska (Mars Petcare): Heska, now part of Mars Petcare, sells in-clinic diagnostics and therapeutic products to companion-animal practices; overlaps in the same vet-channel buyer as AniCell and could potentially house or bundle regenerative SKUs at scale.
- Zoetis: Zoetis is the largest global animal-health company with equine and companion animal portfolios including regenerative and biologic adjacencies (e.g., cytology, PRP, orthobiologics), serving as the dominant broad incumbent AniCell could be acquired by or compete against.
- Dechra Pharmaceuticals: Dechra is a specialty animal-health pharma with strong equine (Equistro, orthopedic) and small-animal therapeutic lines; an active acquirer of niche regenerative/biologic franchises and a logical strategic acquirer of a platform like AniCell.
- Elanco Animal Health: Elanco Animal Health is a major broad-line animal-health company with companion-animal and equine product portfolios, providing scale distribution and R&D resources against which AniCell's niche regenerative offerings must compete for clinic mind-share.
- Boehringer Ingelheim Animal Health: Boehringer Ingelheim Animal Health is a top-tier global animal-health company with equine, livestock, and pet therapeutics; its broad regenerative/biologic R&D budget dwarfs AniCell's and frames the competitive ceiling in advanced veterinary therapeutics.
Direct peers
- Ardent Animal Health: Ardent Animal Health (parent of MediVet Biologics) provides platelet-rich plasma and regenerative therapies for companion animals and horses, directly overlapping AniCell's regenerative product positioning in vet clinics.
- VetStem Biopharma: VetStem Biopharma is a regenerative medicine company offering autologous stem cell therapy services for dogs and horses, the closest functional analogue to AniCell's amnion-derived allograft products and the typical alternative veterinarians compare against.
- MediVet Biologics (Ardent): MediVet Biologics, now part of Ardent Animal Health, sells in-clinic regenerative kits (e.g., in-clinic stem cell kits) used by equine and small animal vets; comparable distribution motion (vet channel) and competitive substitute to AniCell's allograft approach.
Emerging players
- PetVivo Holdings: PetVivo commercializes veterinary medical devices (e.g., Kushion and PrecisePRP) targeting osteoarthritis and tendon/ligament injuries in dogs and horses, competing in overlapping equine/canine regenerative and orthopedic indications.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
AniCell Biotech social profiles
Digital presenceAniCell Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
AniCell Biotech leadership team
Management profileNumber of profiles
Profiles7 records
AniCell Biotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AniCell Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AniCell Biotech
What does AniCell Biotech do?
AniCell Biotech develops and manufactures ready-to-use, all-natural regenerative bioscaffold products derived from equine amniotic material for veterinary use. The portfolio includes two main brands—EquusCell for horses and CanisCell for dogs—with membrane bandages (StemWrap), injectable allografts (AniMatrX, AniMotion), ophthalmic products (AlloOcular, AniOcular), and temperature-independent formulations (AniCell D line). Products support wound management, tendon and ligament injuries, joint inflammation, and ocular conditions without requiring invasive stem cell harvesting.
Is AniCell Biotech a public or private company?
AniCell Biotech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was AniCell Biotech founded?
AniCell Biotech was founded in 2015. It employs 1 to 10 people.
Where is AniCell Biotech based?
AniCell Biotech is headquartered in Chandler, United States, in the North America region.
How does AniCell Biotech make money?
Two revenue lines are on record. Veterinary Product Sales are the primary driver. The others are distribution Partnership Revenue.
Who are AniCell Biotech's main competitors?
Broad incumbents on record are Vetoquinol, Heska (Mars Petcare), Zoetis, Dechra Pharmaceuticals, Elanco Animal Health and Boehringer Ingelheim Animal Health. Direct peers are Ardent Animal Health, VetStem Biopharma and MediVet Biologics (Ardent). PetVivo Holdings is listed as an emerging player.
Does AniCell Biotech have an API?
No public API is recorded for AniCell Biotech.
What industry is AniCell Biotech in?
AniCell Biotech's product category is Veterinary Regenerative Medicine. Its primary akta.pro industry code is HLAMANAK, Point-of-Care Regenerative Kits & Devices (Processing/Delivery), with a secondary code of HLAMANAG, Wound Healing & Dermatologic Regeneration. Its NAICS code is 325414 and its SIC code is 2836.